Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ENOB - Enochian Biosciences: A Follow Through For An HIV Cure

ENOB - Enochian Biosciences: A Follow Through For An HIV Cure

Enochian Biosciences Inc.
  • ENOB announced on June 14, 2021, that it has entered into a 29 million registered direct offering, improving its sustainability.
  • Its Pre-IND request for a potential HIV cure has been approved by the FDA.
  • On June 21, 2021, the company announced that they acquired an exclusive license for an Inhaled Treatment and Prevention Technology to potentially treat and prevent all variants of the Coronavirus.
  • ENOB is expected to burn more cash in the coming years, but on the brighter side, institutions backed them up as they are starting to generate good results for their investors.

For further details see:

Enochian Biosciences: A Follow Through For An HIV Cure
Stock Information
Company Name: Enochian Biosciences Inc.
Stock Symbol: ENOB
Market: NASDAQ
Menu
ENOB ENOB Quote ENOB Short ENOB News ENOB Articles ENOB Message Board
Get ENOB Alerts

News, Short Squeeze, Breakout and More Instantly...